[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649489":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":32,"centralContacts":37,"locations":43,"responsibleParty":60,"collaborators":41,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":41,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":41,"enrollmentInfo":71,"targetDuration":41,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":83,"whyStopped":41,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Case Comprehensive Cancer Center","OTHER",[8,13],{"label":9,"type":6,"description":10,"interventionNames":11},"Monarch Platform","This study is being conducted at a hospital that has two bronchoscopy procedure rooms (BPRs). The unit of the randomization is the BPR day. Each day, one BPR will be randomized to the Monarch platform and the other to the ION platform. Participants in this arm will have undergone their RAB via the Monarch platform.",[12],"Procedure: RAB via the Monarch platform",{"label":14,"type":6,"description":15,"interventionNames":16},"ION Platform","This study is being conducted at a hospital that has two bronchoscopy procedure rooms (BPRs). The unit of the randomization is the BPR day. Each day, one BPR will be randomized to the Monarch platform and the other to the ION platform. Participants in this arm will have undergone their RAB via the ION platform.",[17],"Procedure: RAB via the ION platform",[19,26],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"PROCEDURE","RAB via the Monarch platform","The Monarch™ (Monarch) platform is one of two FDA-cleared robotic platforms currently in clinical use for robotic-assisted bronchoscopy (RAB). It uses a hybrid approach combining electromagnetic tracking and robotic catheter control with a continuously visualizing bronchoscope (4-way articulation). A key feature of the Monarch platform is direct bronchoscopic vision throughout navigation, enabling real-time assessment of the airways and the target lesion.",[9],[25],"Monarch™",{"type":20,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"RAB via the ION platform","The ION™ Endoluminal System (ION) platform is one of two FDA-cleared robotic platforms currently in clinical use for robotic-assisted bronchoscopy (RAB). It uses shape-sensing fiber-optic technology to track catheter position with high precision throughout the bronchial tree.",[14],[31],"ION™ Endoluminal System",[33],{"name":34,"affiliation":35,"role":36},"Sameer K Avasarala, MD","Case Comprehensive Cancer Center, University Hospitals","PRINCIPAL_INVESTIGATOR",[38],{"name":34,"role":39,"phone":40,"phoneExt":41,"email":42},"CONTACT","216-844-3201",null,"Sameer.Avasarala@uhhospitals.org",[44],{"facility":45,"status":41,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center","Cleveland","Ohio","44106","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-81.69541,41.4995,{"lat":55,"lon":54},[58,59],{"name":34,"role":39,"phone":41,"phoneExt":41,"email":42},{"name":34,"role":36,"phone":41,"phoneExt":41,"email":41},{"type":61,"investigatorFullName":41,"investigatorTitle":41,"investigatorAffiliation":41,"oldNameTitle":41,"oldOrganization":41},"SPONSOR","100649489","robotic-systems-evaluation-for-peripheral-pulmonary-lesions-rise-trial-100649489",false,"NCT07735611","Robotic Systems Evaluation for Peripheral Pulmonary Lesions (RISE Trial)","Robotic Systems Evaluation for Peripheral Pulmonary Lesions: A Randomized Trial (RISE Trial)","Inclusion Criteria:\n\n* Age ≥ 18 years at the time of bronchoscopy.\n* Scheduled to undergo navigational bronchoscopy (either ION™ or Monarch™) for the evaluation of a pulmonary lesion at University Hospitals Cleveland Medical Center (UHCMC).\n* Able and willing to provide written informed consent.\n\nExclusion Criteria:\n\n* Enrolled in another clinical trial that requires the use of a specific navigational\u002Frobotic bronchoscopy platform.\n* Enrolled in another bronchoscopy-related clinical trial.\n* Participant or legally authorized representative declines participation.","ALL","18 Years",{"count":72,"type":73},398,"ESTIMATED","INTERVENTIONAL",[76],"NA","This is an investigator-initiated cluster randomized control trial. The primary objective is to compare the diagnostic yield of two Food and Drug Administration (FDA) cleared national robotic assisted bronchoscopy platforms - the Monarch™ Platform and the ION™ Endoluminal System - in participants undergoing bronchoscopy to evaluate peripheral pulmonary lesions (PPLs). Participants will undergo their scheduled robotic assisted bronchoscopy (RAB) using one of these platforms.",[79],"Lung; Node",[81,82,25,31],"Bronchoscopy","Robotic assisted bronchoscopy","NOT_YET_RECRUITING","2026-07-29",{"date":86,"type":87},"2026-07-30","ACTUAL",{"date":89,"type":73},"2026-08",{"date":91,"type":73},"2027-08",{"name":5,"class":6},1]